It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Using index funds for stock diversification can simplify your investment strategy. Explore how they can provide broad market exposure.
23,126 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
MicroStrategy remains tethered to Bitcoin moves, but bullish bets persist as the company expands its digital-asset st...
Early-season Vail Resorts skier visits slipped about 20%, yet a major investor is stepping in with a multihundred-mil...
Nvidia topped quarterly estimates with a sizable revenue beat and raised guidance, yet its stock slipped as traders w...
Learn how to read nuwellis (nuwe) 2025 earnings and what the Q4 results may mean for investors. This guide breaks dow...
Inflation is pushing shoppers to hunt for value, and Target is answering with a broad price-cut program on 3,000 item...
Today’s market shows a blend of volatility and opportunity. Planet Labs led a surge on strong earnings, while broader...
As ELAN reports Q1 2026 earnings, investors want clarity on growth, margins, and guidance. This analysis breaks down ...
Chevron reports stronger-than-expected Q1 2026 results and advancing Hess synergy-driven production, but investors de...
Quantum names showed a broad pullback after a sharp rally, with IonQ down about 7% and D-Wave slipping near 8% as inv...
As inflation lingers and policy shifts loom, traders weigh a defensive, dividend-heavy pick trading under $50 against...
Amcor trades around $39 with a 5.8% forward yield, presenting a potential income safe-haven under $40 as market volat...